A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease

被引：0

作者：

Solomon, Joshua ^{[1
]}

Woodhead, Felix ^{[2
]}

Danoff, Sonye ^{[3
]}

Haynes-Harp, Shana ^{[4
]}

Naik, Tanvi ^{[5
]}

Spino, Cathie ^{[5
]}

Hurwitz, Shelley ^{[6
]}

Maurer, Rie ^{[6
]}

Chambers, Daniel ^{[7
]}

Kolb, Martin ^{[8
]}

Goldberg, Hiliary ^{[6
]}

Rosas, Ivan ^{[4
]}

机构：

[1] Nat Jewish Hlth, Denver, CO USA

[2] Univ Leicester, Leicester, Leics, England

[3] Johns Hopkins Univ, Baltimore, MD USA

[4] Baylor Coll Med, Houston, TX USA

[5] Univ Michigan, Ann Arbor, MI 48109 USA

[6] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA

[7] Univ Queensland, Brisbane, Qld, Australia

[8] McMaster Univ, Hamilton, ON, Canada

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

L10

引用

页码：4105 / 4108

页数：4